Drug Industry Spent Millions to Squelch Talk about High Drug Prices

December 20, 2017

(Scientific American) – Facing bipartisan hostility over high drug prices in an election year, the pharma industry’s biggest trade group boosted revenue by nearly a fourth last year and spread the millions collected among hundreds of lobbyists, politicians and patient groups, new filings show. It was the biggest surge for the Pharmaceutical Research and Manufacturers of America, known as PhRMA, since the group took battle stations to advance its interests in 2009 during the run-up to the Affordable Care Act.

Posted by

Posted in News, Pharma, Public Policy

Recommended Reading